
Andrew Powaleny is Senior Director of Public Affairs at PhRMA and leads the organization's scientific communications, national advocacy events and grassroots initiative, Voters for Cures. He also helped found and currently co-chairs The PRIDE Umbrella, PhRMA’s employee resource group for LGBTQ+ colleagues. Before joining PhRMA in 2015, Andrew worked in public affairs for a small firm in Washington, DC and served as Deputy Press Secretary for the House Committee on Energy and Commerce. Andrew came to Washington, D.C. via Connecticut with a degree from Eastern Connecticut State University where he majored in public policy and government. Andrew is active as a runner and volunteer with the DC Front Runners; and served on its Board of Directors for three years as co-race director. He is also a member of the NLGJA: The Association of LGBTQ Journalists, singer with The Gay Men’s Chorus of Washington, and mentors students through his alumni association with The Fund for American Studies. Andrew is passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.
Recent Posts
Novel medicines approved in 2022 offer increased treatment options for patients

What they are saying: PASTEUR Act can help fight antimicrobial resistance

Mental Illness Awareness Week – A time for reflection

Timely reauthorization of PDUFA and BsUFA is vital to the FDA’s review of medicines

ICYMI: New research builds upon growing body of evidence on value of COVID-19 treatments and vaccines

The Patient Perspective: Government price-setting harms patients

ICYMI: Increase in drug-resistant superbugs during COVID-19 highlights need for policy reforms to address antimicrobial resistance

ICYMI: Antimicrobial resistance spotlighted as growing public health threat

Recognizing LGBTQ+ Pride in biopharmaceutical science

Report: More than 500 medicines in development to treat disorders of the blood
